Cargando…

Elevated serum plasma fibrinogen is associated with advanced tumor stage and poor survival in hepatocellular carcinoma patients

Hyperfibrinogenemia has been reported to be a predictor of poor prognosis in cancer patients, and in hepatocellular carcinoma (HCC) patients, survival remains uncertain and unpredictable. The aim of the present study was to evaluate the association between the level of plasma fibrinogen and overall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Xiang, Long, Qiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2017
Materias:	4500
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5413237/ https://www.ncbi.nlm.nih.gov/pubmed/28445272 http://dx.doi.org/10.1097/MD.0000000000006694

Ejemplares similares

Elevated STIL predicts poor prognosis in patients with hepatocellular carcinoma
por: Song, Huangqin, et al.
Publicado: (2023)

Comparison of 10 noninvasive models for predicting overall survival in patients with intermediate-stage hepatocellular carcinoma
por: Hsu, Wei-Fan, et al.
Publicado: (2021)

Optimizing stage of single large hepatocellular carcinoma: A study with subgroup analysis by tumor diameter
por: Zhong, Jian-Hong, et al.
Publicado: (2017)

Changes of platelet times neutrophil to lymphocyte ratio predict BCLC stage A hepatocellular carcinoma survival
por: Jin, Chen, et al.
Publicado: (2017)

Machine learning methods for accurately predicting survival and guiding treatment in stage I and II hepatocellular carcinoma
por: Li, Xianguo, et al.
Publicado: (2023)

Prognostic value of pretreatment plasma fibrinogen in patients with colorectal cancer: A systematic review and meta-analysis
por: Li, Menglei, et al.
Publicado: (2019)

Survival prediction model for postoperative hepatocellular carcinoma patients
por: Ren, Zhihui, et al.
Publicado: (2017)

Historical Comparison of Overall Survival after Hepatic Resection for Patients With Large and/or Multinodular Hepatocellular Carcinoma
por: Zhong, Jian-Hong, et al.
Publicado: (2015)

Poor adherence and low persistency rates for hepatocellular carcinoma surveillance in patients with chronic hepatitis B
por: Wang, Christina, et al.
Publicado: (2016)

Analysis of the Fibrinogen and Neutrophil–Lymphocyte Ratio in Esophageal Squamous Cell Carcinoma: A Promising Blood Marker of Tumor Progression and Prognosis
por: Arigami, Takaaki, et al.
Publicado: (2015)

The correlation with tumor radiological characteristics and prognosis of patients with early-stage hepatocellular carcinoma receiving transcatheter arterial chemoembolization
por: Lee, Shou-Wu, et al.
Publicado: (2021)

Advanced hepatocellular carcinoma with response to lenvatinib after atezolizumab plus bevacizumab
por: Yano, Shigeki, et al.
Publicado: (2021)

Pretreatment Neutrophil–Lymphocyte Ratio: An Independent Predictor of Survival in Patients With Hepatocellular Carcinoma
por: Gao, Fangyuan, et al.
Publicado: (2015)

Comparative Efficacy of Interventional Therapies for Early-stage Hepatocellular Carcinoma: A PRISMA-compliant Systematic Review and Network Meta-analysis
por: Lan, Tian, et al.
Publicado: (2016)

p16 Methylation was associated with the development, age, hepatic viruses infection of hepatocellular carcinoma, and p16 expression had a poor survival: A systematic meta-analysis (PRISMA)
por: Lv, Xueyou, et al.
Publicado: (2017)

Mast Cells Comprise the Major of Interleukin 17-Producing Cells and Predict a Poor Prognosis in Hepatocellular Carcinoma
por: Tu, Jian-Fei, et al.
Publicado: (2016)

The Relationship Between Serum Interleukin-6 and the Recurrence of Hepatitis B Virus Related Hepatocellular Carcinoma after Curative Resection
por: Sheng, Tao, et al.
Publicado: (2015)

Elevated platelet distribution width predicts poor prognosis in hilar cholangiocarcinoma
por: Li, Bei, et al.
Publicado: (2020)

Sorafenib treatment on Chinese patients with advanced hepatocellular carcinoma: A study on prognostic factors of the viral and tumor status
por: Lee, Shou-Wu, et al.
Publicado: (2019)

Evaluating the predictive power of circulating tumor cells for the prognosis of transarterial chemoembolization treatment on patients with advanced hepatocellular carcinoma
por: Deng, Jun, et al.
Publicado: (2021)

Evaluation of plasma D-dimer for the diagnosis in Chinese patients with hepatocellular carcinoma: A meta-analysis
por: Fang, Ping, et al.
Publicado: (2020)

Prognostic impact of elevated pre-treatment systemic immune-inflammation index (SII) in hepatocellular carcinoma: A meta-analysis
por: Wang, Bolin, et al.
Publicado: (2020)

Barcelona Clinic Liver Cancer Stage B Hepatocellular Carcinoma: Transarterial Chemoembolization or Hepatic Resection?
por: Jianyong, Lei, et al.
Publicado: (2014)

Inflammation-nutrition scope predicts prognosis of early-stage hepatocellular carcinoma after curative resection
por: Zhu, Ying, et al.
Publicado: (2017)

The association between pretreatment serum alkaline phosphatase and prognosis in hepatocellular carcinoma: A meta-analysis
por: Sun, Ping, et al.
Publicado: (2020)

Barcelona clinic liver cancer-stage C hepatocellular carcinoma: A novel approach to subclassification and treatment
por: Jun, Chung Hwan, et al.
Publicado: (2017)

Determinants of Survival After Sorafenib Failure in Patients With BCLC-C Hepatocellular Carcinoma in Real-World Practice
por: Lee, I-Cheng, et al.
Publicado: (2015)

Conditional disease-free survival after liver transplantation for hepatocellular carcinoma: A two-center experience
por: Dong, Jian, et al.
Publicado: (2016)

Postoperative aspartate aminotransferase to lymphocyte ratio index change is an independent predictor of survival in patients with small hepatocellular carcinoma
por: He, Chao, et al.
Publicado: (2017)

Survival benefit of radiofrequency ablation for solitary (3–5 cm) hepatocellular carcinoma: An analysis for nationwide cancer registry
por: Lee, Seung Ho, et al.
Publicado: (2017)

Comparison of survival outcomes of alcohol-related hepatocellular carcinoma with or without liver cirrhosis; a ten-year experience
por: Shin, Jongbeom, et al.
Publicado: (2019)

A novel RNA binding protein-associated prognostic model to predict overall survival in hepatocellular carcinoma patients
por: Liu, Ye, et al.
Publicado: (2021)

Synchronous double primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: A case report and review of the literature
por: Qu, Meng-Meng, et al.
Publicado: (2021)

Hong Kong Liver Cancer Staging System Is Associated With Better Performance for Hepatocellular Carcinoma: Special Emphasis on Viral Etiology
por: Liu, Po-Hong, et al.
Publicado: (2015)

A novel immune signature to predict the prognosis of patients with hepatocellular carcinoma
por: Li, Qinghe, et al.
Publicado: (2021)

Predicting the risk of postoperative liver failure and overall survival using liver and spleen stiffness measurements in patients with hepatocellular carcinoma
por: Wu, Dongbo, et al.
Publicado: (2017)

Limitation of non-transplant treatment and proper timing for liver transplantation in patients with hepatocellular carcinoma considering long-term survival
por: Nomura, Aya, et al.
Publicado: (2020)

Radiofrequency ablation versus microwave ablation for early stage hepatocellular carcinoma: A PRISMA-compliant systematic review and meta-analysis
por: Han, Jie, et al.
Publicado: (2020)

Serum Alpha-Fetoprotein Has High Specificity for the Early Detection of Hepatocellular Carcinoma After Hepatitis C Virus Eradication in Patients
por: Minami, Tatsuya, et al.
Publicado: (2015)

Association of telomere length in peripheral leukocytes with chronic hepatitis B and hepatocellular carcinoma
por: Ma, Qiang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ji673jfj8pp0q0r0g23tcd3dpe